The 17<sup>th</sup> EFMC Short Course on Medicinal Chemistry on Small Molecule Protein Degraders-Reference-Cited by-同舟云学术

The 17^th EFMC Short Course on Medicinal Chemistry on Small Molecule Protein Degraders

Published:2023-10-10 Issue:20 Volume:18 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Ciulli Alessio¹^ORCID,O'Connor Suzanne¹^ORCID,Chung Chun‐Wa²,Hartung Ingo V.³^ORCID,Testa Andrea⁴^ORCID,Daniels Danette L.⁵^ORCID,Heitman Laura H.⁶^ORCID

Affiliation:

1. Centre for Targeted Protein Degradation School of Life Sciences University of Dundee 1 James Lindsay Place Dundee DD1 5JJ Scotland UK

2. GSK R&D Gunnelswood Road Stevenage SG5 4HT UK

3. Merck Healthcare KGaA Frankfurter Straße 250 64293 Darmstadt Germany

4. Amphista Therapeutics Ltd. Cori Building, Granta Park, Great Abington Cambridge CB21 6GQ UK

5. Foghorn Therapeutics 500 Technology Square Cambridge MA 02139 USA

6. Oncode Institute & Division of Drug Discovery and Safety Leiden Academic Centre for Drug Research (LACDR) P. O. Box 9502 2300RA Leiden The Netherlands

Abstract

AbstractThe 17th EFMC Short Course on Medicinal Chemistry took place April 23–26, 2023 in Oegstgeest, near Leiden in the Netherlands. It covered for the first time the exciting topic of Targeted Protein Degradation (full title: Small Molecule Protein Degraders: A New Opportunity for Drug Design and Development). The course was oversubscribed, with 35 attendees and 6 instructors mainly from Europe but also from the US and South Africa, and representing both industry and academia. This report summarizes the successful event, key lectures given and topics discussed.

Funder

Almirall

Amgen

Boehringer Ingelheim

Merck KGaA

AstraZeneca

Janssen Biotech

Promega

Vertex Pharmaceuticals

Publisher

Wiley

Subject